Illustrative image – not actual.ABL Biotechnologies Ltd., based in Chennai has set up a facility with an investment of Rs.40 crore to produce essential fatty acid called DHA (Docasa Hexaenoic Acid) at Tiruchendur. This facility is the first to come up in India and second in the world.
The proposed facility is to become operational in the year 2008. The technology for the DHA project has been developed by ABL that will enable ABL to produce DHA at lower costs and also ensure higher productivity. ABL plans to retail DHA in the form of capsules and fortified foods by the year 2009.
DHA is an omega-3 fatty acid and all fatty acids essential in human diet are contained in either omega-3 or omega-6 fatty acids. The company already has a facility at Tiruchendur that produces beta-carotenes from marine algae called 'Dunaliella salina'.
